Key result
Renal denervation lowers arterial pressure by ~30 mmHg and blunts renal inflammation in hypertension.
Why the study?
It was unclear whether renal denervation mitigates renal inflammation via direct effects on inflammatory signaling or secondary to decreased arterial pressure.
Does renal denervation attenuate renal inflammation directly via loss of renal nerves or secondary to reductions in arterial pressure in DOCA-salt hypertensive rats?
Does renal denervation attenuate renal inflammation directly via loss of renal nerves or secondary to reductions in arterial pressure in DOCA-salt hypertensive rats?
This preclinical study demonstrates that renal nerves directly mediate renal macrophage infiltration and chemotactic cytokine (MCP-1, GRO/KC) production independent of renal perfusion pressure in DOCA-salt hypertension, while establishing urinary cytokines as a real-time biomarker of renal inflammation.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; leaves open whether renal nerve effects on inflammation translate to human hypertension.
Recent reports indicate that, in addition to treating hypertension, renal denervation (RDN) also mitigates renal inflammation. However, because RDN decreases renal perfusion pressure, it is unclear whether these effects are because of the direct effects of RDN on inflammatory signaling or secondary to decreased arterial pressure (AP). Therefore, this study was conducted to elucidate the contribution of renal nerves to renal inflammation in the deoxycorticosterone (DOCA)-salt rat, a model in which RDN decreases AP and abolishes renal inflammation. In Experiment 1, we assessed the temporal changes in renal inflammation by measuring renal cytokines and AP in DOCA-salt rats. Uninephrectomized (1K) adult male Sprague Dawley rats that received surgical RDN or sham (Sham) were administered DOCA (100 mg, SC) and 0.9% saline for 21 days. AP was measured by radiotelemetry, and urinary cytokine excretion was measured repeatedly. In Experiment 2, the contribution of renal nerves in renal inflammation was assessed in a 2-kidney DOCA-salt rat to control for renal perfusion pressure. DOCA-salt treatment was administered after unilateral (U-)RDN. In Experiment 1, DOCA-salt-induced increases in AP and renal inflammation (assessed by urinary cytokines) were attenuated by RDN versus Sham. In Experiment 2, GRO/KC (growth-related oncogene/keratinocyte chemoattractant), MCP (monocyte chemoattractant protein)-1, and macrophage infiltration were lower in the denervated kidney versus the contralateral Sham kidney. No differences in T-cell infiltration were observed. Together, these data support the hypothesis that renal nerves mediate, in part, the development of renal inflammation in the DOCA-salt rat independent of hypertension. The mechanisms and cell-specificity mediating these effects require further investigation.
No takes yet. Share an insight, caveat, or question.
Banek et al. (2019) studied Deoxycorticosterone (DOCA)-salt hypertension and renal inflammation in rats (n=26). Renal denervation (RDN) via surgical ablation and perivascular 10% phenol vs. Sham surgery with 0.9% saline application (contralateral Sham kidney in Experiment 2) was evaluated on 24-hour arterial pressure and renal inflammatory cytokines/immune cell infiltration at 21 days (p=<0.05). Renal denervation attenuated DOCA-salt-induced arterial pressure elevation, reduced renal cytokines by 44-84%, and lowered macrophage infiltration independent of pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: